Role of Stereotactic Body Radiation Therapy in Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma: A Prospective Single Institute Experience

被引:0
|
作者
Pandey, S. [1 ]
Pareek, V. [1 ]
Kumar, R. [1 ,2 ]
Gupta, A. [1 ]
Kunhiparambath, H. [1 ]
Shalimar [1 ]
Gamanagatti, S. [1 ]
Gupta, S. [1 ]
Sharma, S. [1 ]
Binjola, A. [1 ]
Kumar, R. [1 ,2 ]
Pattanaik, J. [1 ]
Praveen, D. V. S. [1 ]
Sanyal, S. [1 ]
Tanwar, M. S. [1 ]
Yadavalli, P. [1 ]
Goel, V. [1 ]
Roy, S. [1 ]
Das, N. [1 ]
Sisodiya, R. [1 ]
机构
[1] All India Inst Med Sci, New Delhi, India
[2] All India Inst Med Sci, Delhi Canc Registry, New Delhi, India
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2722
引用
收藏
页码:E330 / E331
页数:2
相关论文
共 50 条
  • [1] STEREOTACTIC BODY RADIATION THERAPY ON PORTAL VEIN TUMOR THROMBUS OF HEPATOCELLULAR CARCINOMA
    Kwon, J. H.
    Bae, S. H.
    Rha, S. E.
    Jung, S. E.
    Choi, B. O.
    Jang, H. S.
    Jang, J. W.
    Choi, J. Y.
    Yoon, S. K.
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 : S93 - S93
  • [2] Comparison of stereotactic body radiation therapy with and without sorafenib as treatment for hepatocellular carcinoma with portal vein tumor thrombosis
    Que, Jenny
    Wu, Hung-Chang
    Lin, Chia-Hui
    Huang, Chung-, I
    Li, Li-Ching
    Ho, Chung-Han
    [J]. MEDICINE, 2020, 99 (13) : E19660
  • [3] Radiation Therapy for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
    Park, Seung Gyu
    Kim, Jin Hee
    Byun, Sang Jun
    Kim, Ok Bae
    Hwang, Jae Seok
    Oh, Young Kee
    Choi, Tae Jin
    [J]. RADIATION ONCOLOGY JOURNAL, 2011, 29 (01): : 36 - 43
  • [4] Is hepatocellular carcinoma complicated with portal vein tumor thrombosis potentially curable by radiotherapy in the form of stereotactic body radiation therapy?
    Srivastava, Astha
    Parambath, Haresh Kunhi
    Ramdulari, Anjali V.
    Saxena, Harsh
    Kumar, Rishabh
    Pandey, Suyash
    Shalimar, S.
    Gupta, Subhash
    Jee, Babban
    [J]. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2022, 98 (10) : 1495 - 1509
  • [5] Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma
    Toya, Ryo
    Murakamia, Ryuji
    Baba, Yuji
    Nishimura, Ryuichi
    Morishita, Shoji
    Ikeda, Osamu
    Kawanaka, Koichi
    Beppu, Toru
    Sugiyama, Shinichi
    Sakamoto, Takashi
    Yamashita, Yasuyuki
    Oya, Natsuo
    [J]. RADIOTHERAPY AND ONCOLOGY, 2007, 84 (03) : 266 - 271
  • [6] A Preliminary Analysis of Robotic Radiosurgery Stereotactic Body Radiation Therapy With or Without Sorafenib for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
    Que, J. Y.
    Lin, L. C.
    Lin, C. H.
    Lin, K. L.
    Lin, Y. W.
    Yang, C. C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E180 - E180
  • [7] Stereotactic-body radiotherapy for portal vein tumor thrombosis in hepatocellular carcinoma patients
    Jeong, Bae Kwon
    Choi, Hoon Sik
    Kang, Ki Mun
    Jeong, Hojin
    Lee, Yun Hee
    Ha, In Bong
    Song, Jin Ho
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [8] Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis
    Yongjie Shui
    Wei Yu
    Xiaoqiu Ren
    Yinglu Guo
    Jing Xu
    Tao Ma
    Bicheng Zhang
    Jianjun Wu
    Qinghai Li
    Qiongge Hu
    Li Shen
    Xueli Bai
    Tingbo Liang
    Qichun Wei
    [J]. Radiation Oncology, 13
  • [9] Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis
    Shui, Yongjie
    Yu, Wei
    Ren, Xiaoqiu
    Guo, Yinglu
    Xu, Jing
    Ma, Tao
    Zhang, Bicheng
    Wu, Jianjun
    Li, Qinghai
    Hu, Qiongge
    Shen, Li
    Bai, Xueli
    Liang, Tingbo
    Wei, Qichun
    [J]. RADIATION ONCOLOGY, 2018, 13
  • [10] Stereotactic body radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis
    Kang, Jingbo
    Nie, Qing
    Du, Rui
    Zhang, Liping
    Zhang, Jun
    Li, Qiliang
    Li, Jianguo
    Qi, Wenjie
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (01) : 43 - 50